Long-term glycaemic effects of pioglitazone in triple oral therapy: Results from PROactive

被引：0
|
作者：
Charbonnell, B.
Scheen, A.
机构：
[1] Hop Hotel Dieu, Clin Endocrinol, Nantes, France
[2] Univ Liege, Div Diabet Nutr & Metab Disorders, B-4000 Liege, Belgium
来源：
DIABETOLOGIA | 2006年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0805
引用
收藏
页码：488 / 489
页数：2
相关论文
共 50 条
  • [1] Pioglitazone in triple oral therapy: Long-term glycemic results from PROactive
    Charbonnel, Bernard
    Scheen, Andre
    [J]. DIABETES, 2006, 55 : A106 - A107
  • [2] Long-term glycaemic control with metformin-sulphonylurea-pioglitazone triple therapy in PROactive (PROactive 17)
    Scheen, A. J.
    Tan, M. H.
    Betteridge, D. J.
    Birkeland, K.
    Schmitz, O.
    Charbonnel, B.
    [J]. DIABETIC MEDICINE, 2009, 26 (10) : 1033 - 1039
  • [3] Long-term glycaemic effects of pioglitazone compared with placebo as add-on treatment to metformin or sulphonylurea monotherapy in PROactive (PROactive 18)
    Scheen, A. J.
    Tan, M. H.
    Betteridge, D. J.
    Birkeland, K.
    Schmitz, O.
    Charbonnel, B.
    [J]. DIABETIC MEDICINE, 2009, 26 (12) : 1242 - 1249
  • [4] Long-term pioglitazone treatment improves markers of liver function: Results from PROactive
    Heine, Robert
    Schindhelm, Roger
    Diamant, Michaela
    [J]. DIABETES, 2006, 55 : A115 - A116
  • [5] The effects of long-term pioglitazone therapy on lipid profiles in high-risk type 2 diabetes patients: results from PROactive
    Spanheimer, R.
    Tan, M.
    Yates, J.
    [J]. DIABETOLOGIA, 2006, 49 : 69 - 70
  • [6] Glycaemic and nonglycaemic effects of pioglitazone in triple oral therapy of patients with type 2 diabetes
    Dorkhan, M.
    Magnusson, M.
    Frid, A.
    Grubb, A.
    Groop, L.
    Jovinge, S.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2006, 260 (02) : 125 - 133
  • [7] Effects of long-term pioglitazone therapy on serum lipid profiles in high-risk type 2 diiabetes patients: results from PROactive
    Spanheimer, R.
    Tan, M.
    Yates, J.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 850 - 851
  • [8] Long-Term Lipid Effects of Pioglitazone by Baseline Anti-Hyperglycemia Medication Therapy and Statin Use from the PROactive Experience (PROactive 14)
    Spanheimer, Robert
    Betteridge, D. John
    Tan, Meng H.
    Ferrannini, Ele
    Charbonnel, Bernard
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2009, 104 (02): : 234 - 239
  • [9] Effects of long-term treatment with pioglitazone on lipid levels in patients receiving statin therapy at baseline in the PROactive study
    Spanheimer, Robert
    Tan, Meng
    Yates, John
    Charbonnel, Bernard
    Ferrannini, Ele
    [J]. DIABETES, 2007, 56 : A237 - A237
  • [10] Long-term glycaemic control with pioglitazone in patients with type 2 diabetes
    Campbell, IW
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (02) : 192 - 200
12345